SSRI Antidepressant Birth Defect Lawsuits

We are no longer accepting SSRI medication cases.

Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed for the treatment of depression, anxiety, panic disorder, post-traumatic stress disorder, and social phobia. The use of SSRIs during the first trimester of pregnancy has been linked to babies born with birth defects that can be severe and even life threatening.

What SSRI drugs are in question?

SSRI drugs linked to an increased risk of birth defects include:

  • Celexa® (citalopram)
  • Cipralex® (escitalopram)
  • Cymbalta® (duloxetine)
  • Effexor® (venlafaxine)
  • Lexapro® (escitalopram)
  • Luvox® (fluvoxamine)
  • Paxil® (paroxetine)
  • Prozac® (fluoxetine)
  • Remeron® (mirtazapine)
  • Sarafem® (fluoxetine)
  • Symbyax® (olanzapine/fluoxetine)
  • Wellbutrin® (bupropion)
  • Zoloft® (sertraline)

What should I know about the link between these drugs and birth defects?

Several medical studies have provided evidence that exposure to SSRI drugs in the first trimester of pregnancy increased the risk for major congenital malformations, especially cardiac (heart) defects.

The U.S. Food and Drug Administration (FDA) reported that one study also showed infants born to mothers who took SSRIs after the 20th week of pregnancy were six times more likely to have persistent pulmonary hypertension (PPHN) than infants born to mothers who did not take antidepressants during pregnancy.

Types of Birth Defects Linked to SSRI Antidepressants

Birth defects that may result from the use of SSRIs during pregnancy can include:

  • Abdominal wall defect (omphalocele)
  • Atrial septal defect (ASD)
  • Cardiac defects
  • Club foot
  • Cranial skull defect (craniosynostosis)
  • Developmental delays
  • Fetal death
  • Gastroschisis (stomach/intestines outside of body)
  • Heart murmurs
  • Hole in heart wall
  • Hypoplastic left heart syndrome
  • Hypoplastic right heart syndrome
  • Oral cleft
  • Persistent pulmonary hypertension
  • Pulmonary atresia
  • Renal defects
  • Required heart surgery or transplant
  • Spina bifida
  • Tetralogy of Fallot
  • Transposition of great arteries
  • Tricuspid or mitral heart valve defect
  • Trilogy of Fallot
  • Ventricular septal defect (VSD)

Celexa® and Lexapro® are registered trademarks of Forest Pharmaceuticals, Inc. Cipralex® is a registered trademark of H. Lundbeck A/S. Cymbalta®, Prozac® and Symbyax® are registered trademarks of Eli Lilly and Company. Effexor® and Zoloft® are registered trademarks of Pfizer, Inc. Luvox® is a registered trademark of Abbott Products, Inc. Paxil® and Wellbutrin® are registered trademarks of GlaxoSmithKline. Remeron® is a registered trademark of N.V. Organon. Sarafem® is a registered trademark of Warner Chilcott. All trademarks are used to identify the products in question.

This law firm is not associated with, sponsored by, or affiliated with the U.S. Food and Drug Administration or any of the trademarks or companies used on this page.